Nirav Desai, MD
Affiliate Staff, Division of Gastroenterology, Hepatology and Nutrition
Instructor of Pediatrics, Harvard Medical School
Image
Nirav Desai, MD
Affiliate Staff, Division of Gastroenterology, Hepatology and Nutrition
Instructor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Certifications
American Board of Pediatrics (General)
American Board of Pediatrics (Gastroenterology)
Publications
Effect of randomized treatment withdrawal of budesonide oral suspension on clinically relevant efficacy outcomes in patients with eosinophilic esophagitis: a post hoc analysis. View Abstract
Effect of Esophageal Dilation History on Efficacy Outcomes in Patients With Eosinophilic Esophagitis Receiving Budesonide Oral Suspension. View Abstract
Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Budesonide Oral Suspension in Healthy Adult Participants: A Randomized Phase 1 Study. View Abstract
Treatment Patterns and Persistent Disease Activity in Patients With Eosinophilic Esophagitis: A Retrospective Cohort Study. View Abstract
Qualitative assessment of the suitability of the Dysphagia Symptom Questionnaire to monitor dysphagia in children aged 7-10 years with eosinophilic esophagitis. View Abstract
Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic Esophagitis. View Abstract
Editorial: safety of topical steroids designed specifically for eosinophilic oesophagitis - new data bring new questions. Authors' reply. View Abstract
Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1-3 clinical trials. View Abstract
Pharmacokinetics of Budesonide Oral Suspension in Children and Adolescents With Eosinophilic Esophagitis. View Abstract
Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study. View Abstract
Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study. View Abstract
Reply. View Abstract
Long-Term Treatment of Eosinophilic Esophagitis With Budesonide Oral Suspension. View Abstract
Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial. View Abstract
Pediatric Gastroenterology, Hepatology, and Nutrition Entrustable Professional Activities: Development of an Assessment Tool and Curricular Resources. View Abstract
Understanding the Bariatric Patient Perspective in the National Patient-Centered Clinical Research Network (PCORnet) Bariatric Study. View Abstract
Hepatotoxicity of Statins as Determined by Serum Alanine Aminotransferase in a Pediatric Cohort With Dyslipidemia. View Abstract
Clinical Practice Approach to Nonalcoholic Fatty Liver Disease by Pediatric Gastroenterologists in the United States. View Abstract
Comparative effectiveness of bariatric procedures among adolescents: the PCORnet bariatric study. View Abstract
Statin-Associated Myopathy in a Pediatric Preventive Cardiology Practice. View Abstract
Adolescent Dyslipidemia and Standardized Lifestyle Modification: Benchmarking Real-World Practice. View Abstract
Update on Adolescent Bariatric Surgery. View Abstract
Correlates of Achieving Statin Therapy Goals in Children and Adolescents with Dyslipidemia. View Abstract
Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients. View Abstract
Open repair of large abdominal wall hernias with and without components separation; an analysis from the ACS-NSQIP database. View Abstract
Severe hypercholesterolemia and liver disease in a 3-year old. View Abstract
Managing adolescent obesity and the role of bariatric surgery. View Abstract
Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans. View Abstract
A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia. View Abstract
Cellular localization and functional significance of CYP3A4 in the human epileptic brain. View Abstract
Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity. View Abstract
Regulation of no synthesis induced by inflammatory mediators in RAW264.7 cells: collagen prevents inhibition by osteopontin. View Abstract